163 related articles for article (PubMed ID: 32543142)
21. Identification of miRNA-34a and miRNA-155 as prognostic markers for mantle cell lymphoma.
He J; Xi Y; Gao N; Xu E; Chang J; Liu J
J Int Med Res; 2021 May; 49(5):3000605211016390. PubMed ID: 34024195
[TBL] [Abstract][Full Text] [Related]
22. miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11.
Zhou K; Feng X; Wang Y; Liu Y; Tian L; Zuo W; Yi S; Wei X; Song Y; Qiu L
Exp Hematol; 2018 Feb; 58():27-34.e1. PubMed ID: 29158064
[TBL] [Abstract][Full Text] [Related]
23. The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival.
Wang X; Asplund AC; Porwit A; Flygare J; Smith CI; Christensson B; Sander B
Br J Haematol; 2008 Oct; 143(2):248-52. PubMed ID: 18729857
[TBL] [Abstract][Full Text] [Related]
24. SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma.
Morsy MHA; Lilienthal I; Lord M; Merrien M; Wasik AM; Sureda-Gómez M; Amador V; Johansson HJ; Lehtiö J; Garcia-Torre B; Martin-Subero JI; Tsesmetzis N; Tao S; Schinazi RF; Kim B; Sorteberg AL; Wickström M; Sheppard D; Rassidakis GZ; Taylor IA; Christensson B; Campo E; Herold N; Sander B
Blood; 2024 Jan; 143(19):1953-1964. PubMed ID: 38774451
[TBL] [Abstract][Full Text] [Related]
25. Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma.
Mohanty A; Sandoval N; Phan A; Nguyen TV; Chen RW; Budde E; Mei M; Popplewell L; Pham LV; Kwak LW; Weisenburger DD; Rosen ST; Chan WC; Müschen M; Ngo VN
Blood; 2019 Jan; 133(4):306-318. PubMed ID: 30530749
[TBL] [Abstract][Full Text] [Related]
26. SOX11 expression in mantle cell lymphoma.
Xu W; Li JY
Leuk Lymphoma; 2010 Nov; 51(11):1962-7. PubMed ID: 20919851
[TBL] [Abstract][Full Text] [Related]
27. SOX11 regulates the pro-apoptosis signal pathway and predicts a favorable prognosis of mantle cell lymphoma.
Yang W; Wang Y; Yu Z; Li Z; An G; Liu W; Lv R; Ma L; Yi S; Qiu L
Int J Hematol; 2017 Aug; 106(2):212-220. PubMed ID: 28429312
[TBL] [Abstract][Full Text] [Related]
28. Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1.
Teo AE; Chen Z; Miranda RN; McDonnell T; Medeiros LJ; McCarty N
Leukemia; 2016 Mar; 30(3):580-93. PubMed ID: 26073757
[TBL] [Abstract][Full Text] [Related]
29. The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples.
Zhang YH; Liu J; Dawlett M; Guo M; Sun X; Gong Y
Cancer Cytopathol; 2014 Dec; 122(12):892-7. PubMed ID: 25056830
[TBL] [Abstract][Full Text] [Related]
30. SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma.
Abdelrazak Morsy MH; Lilienthal I; Lord M; Merrien M; Wasik AM; Sureda-Gómez M; Amador V; Johansson HJ; Lehtiö J; Garcia-Torre B; Martin-Subero JI; Tsesmetzis N; Tao S; Schinazi RF; Kim B; Sorteberg AL; Wickström M; Sheppard D; Rassidakis GZ; Taylor IA; Christensson B; Campo E; Herold N; Sander B
Blood; 2024 May; 143(19):1953-1964. PubMed ID: 38237141
[TBL] [Abstract][Full Text] [Related]
31. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype.
Mozos A; Royo C; Hartmann E; De Jong D; Baró C; Valera A; Fu K; Weisenburger DD; Delabie J; Chuang SS; Jaffe ES; Ruiz-Marcellan C; Dave S; Rimsza L; Braziel R; Gascoyne RD; Solé F; López-Guillermo A; Colomer D; Staudt LM; Rosenwald A; Ott G; Jares P; Campo E
Haematologica; 2009 Nov; 94(11):1555-62. PubMed ID: 19880778
[TBL] [Abstract][Full Text] [Related]
32. Increased tumour angiogenesis in SOX11-positive mantle cell lymphoma.
Petrakis G; Veloza L; Clot G; Gine E; Gonzalez-Farre B; Navarro A; Bea S; Martínez A; Lopez-Guillermo A; Amador V; Ribera-Cortada I; Campo E
Histopathology; 2019 Nov; 75(5):704-714. PubMed ID: 31173643
[TBL] [Abstract][Full Text] [Related]
33. SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma.
De Bolòs A; Sureda-Gómez M; Carreras-Caballé M; Rodríguez ML; Clot G; Beà S; Giné E; Campo E; Balsas P; Amador V
Sci Rep; 2024 Apr; 14(1):7863. PubMed ID: 38570586
[TBL] [Abstract][Full Text] [Related]
34. SOX11, a key oncogenic factor in mantle cell lymphoma.
Beekman R; Amador V; Campo E
Curr Opin Hematol; 2018 Jul; 25(4):299-306. PubMed ID: 29738333
[TBL] [Abstract][Full Text] [Related]
35. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients.
Xu J; Wang L; Li J; Saksena A; Wang SA; Shen J; Hu Z; Lin P; Tang G; Yin CC; Wang M; Medeiros LJ; Li S
Am J Surg Pathol; 2019 May; 43(5):710-716. PubMed ID: 30768440
[TBL] [Abstract][Full Text] [Related]
36. Assessment of SOX11 expression in routine lymphoma tissue sections: characterization of new monoclonal antibodies for diagnosis of mantle cell lymphoma.
Soldini D; Valera A; Solé C; Palomero J; Amador V; Martin-Subero JI; Ribera-Cortada I; Royo C; Salaverria I; Beà S; Gonzalvo E; Johannesson H; Herrera M; Colomo L; Martinez A; Campo E
Am J Surg Pathol; 2014 Jan; 38(1):86-93. PubMed ID: 24145648
[TBL] [Abstract][Full Text] [Related]
37. SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma.
Hsiao SC; Cortada IR; Colomo L; Ye H; Liu H; Kuo SY; Lin SH; Chang ST; Kuo TU; Campo E; Chuang SS
Histopathology; 2012 Oct; 61(4):685-93. PubMed ID: 22642745
[TBL] [Abstract][Full Text] [Related]
38. SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma.
Balsas P; Palomero J; Eguileor Á; Rodríguez ML; Vegliante MC; Planas-Rigol E; Sureda-Gómez M; Cid MC; Campo E; Amador V
Blood; 2017 Jul; 130(4):501-513. PubMed ID: 28533307
[TBL] [Abstract][Full Text] [Related]
39. Polyclonal antibody targeting SOX11 cannot differentiate mantle cell lymphoma from B-cell non-Hodgkin lymphomas.
Zhang LN; Cao X; Lu TX; Fan L; Wang L; Xu J; Zhang R; Zou ZJ; Wu JZ; Li JY; Xu W
Am J Clin Pathol; 2013 Dec; 140(6):795-800. PubMed ID: 24225745
[TBL] [Abstract][Full Text] [Related]
40. Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma.
Emruli VK; Olsson R; Ek F; Ek S
BMC Cancer; 2016 Jul; 16():493. PubMed ID: 27430213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]